Surface-Enhanced Raman Spectroscopy (SERS) for the Characterization of the Blood Serum Samples of Ovarian Cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Spectroscopy Techniques in Biomedical and Chemical Research · Spectroscopy and Chemometric Analyses · Laser-induced spectroscopy and plasma
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Gaona-Luviano P, Medina-Gaona LA, Magaña-Pérez K (2020) Epidemiology of ovarian cancer. Chin Clin Oncol 9(4):4710.21037/cco-20-34 ↗
2. Ferlay J (1999) EUCAN: cancer incidence, mortality and prevalence in the European union 1996. IARC Cancer Base 4
3. Colombo N et al (2006) Ovarian cancer. Crit Rev Oncol Hematol 60(2):159–17910.1016/j.critrevonc.2006.03.004 ↗
4. Stewart C, Ralyea C, Lockwood S (2019) Ovarian cancer: an integrated review. In: Seminars in oncology nursing. Elsevier10.1016/j.soncn.2019.02.001 ↗
5. Salehi F et al (2008) Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health Part B 11(3–4):301–32110.1080/10937400701876095 ↗
6. Baroutsou V et al (2021) Interventions facilitating family communication of genetic testing results and cascade screening in hereditary breast/ovarian cancer or lynch syndrome: a systematic review and meta-analysis. Cancers 13(4):92510.3390/cancers13040925 ↗
7. O’Shea AS (2021) Clinical staging of ovarian cancer. In: Ovarian cancer: methods and protocols. Springer US, New York, pp 3–10
8. Pal MK, Rashid M, Bisht M (2015) Multiplexed magnetic nanoparticle-antibody conjugates (MNPs-ABS) based prognostic detection of ovarian cancer biomarkers, CA-125, β-2M and ApoA1 using fluorescence spectroscopy with comparison of surface plasmon resonance (SPR) analysis. Biosens Bioelectron 73:146–15210.1016/j.bios.2015.05.051 ↗
9. Schwartz D et al (2022) Ovarian cancer detection using optical coherence tomography and convolutional neural networks. Neural Comput Appl 34(11):8977–898710.1007/s00521-022-06920-3 ↗
10. Lu S et al (2022) NIR-II fluorescence/photoacoustic imaging of ovarian cancer and peritoneal metastasis. Nano Res 15(10):9183–919110.1007/s12274-022-4592-z ↗
11. van Vliet-Pérez SM et al (2022) Hyperspectral imaging for tissue classification after advanced stage ovarian cancer surgery—a pilot study. Cancers 14(6):142210.3390/cancers14061422 ↗
12. Williams RM et al (2018) Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant. Sci Adv 4(4):1eaaq109010.1126/sciadv.aaq1090 ↗
13. ul Huda N et al. (2025) Raman spectroscopy for medical diagnostics: from in vitro biofluid assays to in vivo cancer detection, in Applied Raman Spectroscopy. Elsevier. p. 185–21210.1016/B978-0-443-21834-7.00012-8 ↗
14. Kong K et al (2015) Raman spectroscopy for medical diagnostics—From in-vitro biofluid assays to in-vivo cancer detection. Adv Drug Deliv Rev 89:121–13410.1016/j.addr.2015.03.009 ↗
15. Ehsan U et al (2023) Surface-enhanced Raman spectroscopy of centrifuged blood serum samples of diabetic type II patients by using 50KDa filter devices. Spectrochim Acta Part A Mol Biomol Spectrosc 293:12245710.1016/j.saa.2023.122457 ↗
16. Amber A et al (2023) Surface-enhanced Raman spectroscopy for the characterization of different anatomical subtypes of oral cavity cancer. Photodiagn Photodyn Ther 42:10360710.1016/j.pdpdt.2023.103607 ↗
17. Schlücker S (2014) Surface-enhanced Raman spectroscopy: concepts and chemical applications. Angew Chem Int Ed 53(19):4756–479510.1002/anie.201205748 ↗
18. Huda NU et al (2023) Synthesis, characterization, and evaluation of antifungal activity of 1-Butyl-3-hexyl-1 H-imidazol-2 (3 H)-selenone by surface-enhanced Raman spectroscopy. ACS Omega10.1021/acsomega.3c05436 ↗
19. Vennila Sigamani S (2021) A 3D SERS device for highly sensitive detection of organic chemicals in liquid
20. Cassar RN et al (2014) Synthesis of size tunable monodispersed silver nanoparticles and the effect of size on SERS enhancement. Vib Spectrosc 71:41–4610.1016/j.vibspec.2014.01.004 ↗
21. Bashir S et al (2021) Surface-enhanced Raman spectroscopy for the identification of tigecycline-resistant E. coli strains. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 258:11983110.1016/j.saa.2021.119831 ↗
22. Tan Y et al (2017) Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma. Lipids Health Dis 16:1–910.1186/s12944-017-0465-y ↗
23. Ye L et al (2023) RNA epigenetic modifications in ovarian cancer: the changes, chances, and challenges. Wiley Interdisciplinary Reviews: RNA e178410.1002/wrna.1784 ↗
24. Zuberi M et al (2016) Utility of serum miR-125b as a diagnostic and prognostic indicator and its alliance with a panel of tumor suppressor genes in epithelial ovarian cancer. PLoS One 11(4):e015390210.1371/journal.pone.0153902 ↗
25. Owen S et al (2017) ShenLingLan influences the attachment and migration of ovarian cancer cells potentially through the GSK3 pathway. Medicines 4(1):1010.3390/medicines4010010 ↗
26. Tian W et al (2022) Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. Cell Death Dis 13(1):6410.1038/s41419-022-04510-8 ↗
27. Shen L, Zhan X (2022) Mitochondrial dysfunction pathway alterations offer potential biomarkers and therapeutic targets for ovarian cancer. Oxidative Med Cell Longevity 202210.1155/2022/5634724 ↗
28. Ray U et al (2017) Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells. Mol Oncol 11(5):491–51610.1002/1878-0261.12046 ↗
29. Hwang K-A et al (2011) Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab Animal Res 27(2):99–10710.5625/lar.2011.27.2.99 ↗
30. Avci E et al (2022) Label-free surface enhanced raman spectroscopy for cancer detection. Cancers 14(20):502110.3390/cancers14205021 ↗
31. Lei J et al (2021) Label-free surface-enhanced Raman spectroscopy for diagnosis and analysis of serum samples with different types lung cancer. Spectrochim Acta Part A Mol Biomol Spectrosc 261:12002110.1016/j.saa.2021.120021 ↗
32. Vargas-Obieta E et al (2016) Breast cancer detection based on serum sample surface enhanced Raman spectroscopy. Lasers Med Sci 31:1317–132410.1007/s10103-016-1976-x ↗
33. Xiao R et al (2016) Non-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopy. Nanomedicine: Nanotechnology, Biology and Medicine 12(8):2475–248410.1016/j.nano.2016.07.014 ↗
34. Li S-X et al (2013) Study of support vector machine and serum surface-enhanced Raman spectroscopy for noninvasive esophageal cancer detection. J Biomed Opt 18(2):027008–02700810.1117/1.JBO.18.2.027008 ↗
35. Stone N et al (2004) Raman spectroscopy for identification of epithelial cancers. Faraday Discuss 126:141–15710.1039/b304992b ↗
36. González-Solís JL et al (2014) Cervical cancer detection based on serum sample Raman spectroscopy. Lasers Med Sci 29:979–98510.1007/s10103-013-1447-6 ↗
37. Ditta A et al (2019) Principal components analysis of Raman spectral data for screening of Hepatitis C infection. Spectrochim Acta Part A Mol Biomol Spectrosc 221:11717310.1016/j.saa.2019.117173 ↗
38. Cao X et al (2018) Label-free detection of human serum using surface-enhanced Raman spectroscopy based on highly branched gold nanoparticle substrates for discrimination of non-small cell lung cancer. J Chem 2018:1–1310.1155/2018/9012645 ↗
39. Nargis H et al (2021) Comparison of surface enhanced Raman spectroscopy and Raman spectroscopy for the detection of breast cancer based on serum samples. Spectrochim Acta Part A Mol Biomol Spectrosc 246:11903410.1016/j.saa.2020.119034 ↗
40. Akbar S et al (2022) Surface-enhanced Raman spectroscopic (SERS) characterization of low molecular weight fraction of the serum of breast cancer patients with principal component analysis (PCA) and partial least square-discriminant analysis (PLS-DA). Anal Lett 55(10):1588–160410.1080/00032719.2021.2017948 ↗
41. Bari RZA et al (2022) Surface-enhanced Raman spectroscopic analysis of centrifugally filtered HBV serum samples. Photodiagn Photodyn Ther 38:10280810.1016/j.pdpdt.2022.102808 ↗
42. Verma A et al (2015) Association between lipid profile and ovarian cancer in women of north India. Int J Biomed Res 6:488–49210.7439/ijbr.v6i7.2272 ↗
43. Raza A et al (2023) Surface-enhanced Raman spectral characterization of antifungal activity of selenium and zinc based organometallic compounds. Spectrochim Acta Part A Mol Biomol Spectrosc 285:12190310.1016/j.saa.2022.121903 ↗
44. Tariq A et al (2024) Characterization of Aspergillus Niger DNA by surface-enhanced Raman spectroscopy (SERS) with principal component analysis (PCA) and partial least square discriminant analysis (PLS-DA) with application for the production of cellulose. Analytical Lett 57(7):1123–113610.1080/00032719.2023.2241938 ↗
45. Shahbaz M et al (2023) Qualitative and quantitative analysis of azithromycin as solid dosage by Raman spectroscopy. ACS Omega 8(39):36393–3640010.1021/acsomega.3c05245 ↗
46. Tahseen H et al (2024) Surface-enhanced Raman spectroscopy for comparison of biochemical profile of bacteriophage sensitive and resistant methicillin-resistant Staphylococcus aureus (MRSA) strains. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 310:12396810.1016/j.saa.2024.123968 ↗
47. Akram MW et al (2025) Surface-enhanced Raman spectral profiling of gamma radiation-induced mutations in Aspergillus Niger supernatant samples. 1–1210.1007/s11468-025-02892-x ↗
48. Borba FDSL, Honorato RS, de Juan A (2015) Use of Raman spectroscopy and chemometrics to distinguish blue ballpoint pen inks. Forensic Sci Int 249:73–8210.1016/j.forsciint.2015.01.027 ↗